Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

10.75
Delayed Data
As of Mar 24
 -0.11 / -1.01%
Today’s Change
10.35
Today|||52-Week Range
38.50
-25.96%
Year-to-Date
Can This Pharma Stock Withstand the 'Trump Effect'?
Mar 25 / TheStreet.com - Paid Partner Content
Valeant's (VRX) Glaucoma Candidate Gets PDUFA Date from FDA
Mar 21 / Zacks.com - Paid Partner Content
Bill Ackman Finally Pukes: Beware of False Narratives
Mar 25 / GuruFocus News - Paid Partner Content
TransDigm Looks Cheap - But No Thanks
Mar 21 / GuruFocus News - Paid Partner Content
Francis Chou Comments on Valeant
Mar 24 / GuruFocus News - Paid Partner Content
TransDigm: Cheap but No Thanks
Mar 21 / GuruFocus News - Paid Partner Content
Valeant: The End Of The Michael Pearson Era
Mar 23 / Investing Channel - Paid Partner Content
Jazz Sleep Disorder Drug Positive in Phase III Studies
Mar 21 / Zacks.com - Paid Partner Content
Pernix: An Investor's Rationale to Staying Long
Mar 23 / GuruFocus News - Paid Partner Content
Biotech Bull Making a Comeback
Mar 21 / Zacks.com - Paid Partner Content
Bill Ackman to Attend Ira Sohn Conference
Mar 23 / TheStreet.com - Paid Partner Content
Chipotle, Herbalife, Sears: Doug Kass' Views
Mar 20 / TheStreet.com - Paid Partner Content
Troubled drug company pays CEO $63 million
Mar 23 / CNNMoney.com
Stocks Decline to Their 3-Year Lows
Mar 19 / GuruFocus News - Paid Partner Content
The 'Dogs' of Wall Street: Here's A Look at Some of the Worst Performing Stocks of Th...
Mar 23 / TheStreet.com - Paid Partner Content
Valeant - It's Not a Game of Chess Part II
Mar 19 / GuruFocus News - Paid Partner Content
Saba Capital Management, L.P. Buys Allergan PLC, Alpine Total Dynamic Dividend Fund, ...
Mar 23 / GuruFocus News - Paid Partner Content
Valeant (VRX) Shares up on ValueAct's 5.2% Stake Increase
Mar 17 / Zacks.com - Paid Partner Content
Democrats Target Trump SEC Pick Clayton Over Conflicts
Mar 23 / TheStreet.com - Paid Partner Content
Company News for March 15, 2017
Mar 15 / Zacks.com - Paid Partner Content
Valeant CEO Compensation Revealed, Shares Climb
Mar 23 / TheStreet.com - Paid Partner Content
After Valeant, Here are 5 Drug Stocks Bill Ackman Should Buy Instead
Mar 15 / Zacks.com - Paid Partner Content
Trump's Wall Street cop promises 'no favoritism' despite ties to banks
Mar 23 / CNNMoney.com
Why Valeant Pharmaceuticals, Tilly's, and Pandora Media Slumped Today
Mar 14 / MotleyFool.com - Paid Partner Content
Investors take a breath; Takeover talk; Watching the Fed
Mar 23 / CNNMoney.com
Why Valeant Pharmaceuticals Is Down 10% Today
Mar 14 / MotleyFool.com - Paid Partner Content
Silver Point Capital L.P. Buys Basic Energy Services, Key Energy Services, Penn Virgi...
Mar 22 / GuruFocus News - Paid Partner Content
TransDigm Stock Upgraded: What You Need to Know
Mar 14 / MotleyFool.com - Paid Partner Content
Trump's Wall Street cop is a big defender of Wall Street
Mar 22 / CNNMoney.com
The Smartest Move Billionaire Bill Ackman Made Was Selling His Remaining Valeant Stak...
Mar 14 / MotleyFool.com - Paid Partner Content
Valeant Closes Down Slightly After Completing Refi
Mar 22 / TheStreet.com - Paid Partner Content
NYSE weathers the storm; Bill Ackman ditches Valeant; Pound hammered
Mar 14 / CNNMoney.com
Zacks Investment Ideas feature highlights: Nasdaq Biotechnology Index, Gilead, Valean...
Mar 22 / Zacks.com - Paid Partner Content
3 Companies That Probably Won't Survive Till 2019
Mar 13 / MotleyFool.com - Paid Partner Content
Saba Capital Management, L.P. Buys Allergan PLC, Alpine Total Dynamic Dividend Fund, ...
Mar 21 / GuruFocus News - Paid Partner Content
Dow goes for 13; GDP update; Targeting earnings
Feb 28 / CNNMoney.com
Benzinga's Option Alert Recap From March 21
Mar 21 / Benzinga - Paid Partner Content